172 related articles for article (PubMed ID: 35326574)
1. A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy.
Androulakis I; Mestrom RMC; Christianen MEMC; Kolkman-Deurloo IK; van Rhoon GC
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326574
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous ThermoBrachytherapy: Electromagnetic Simulation Methods for Fast and Accurate Adaptive Treatment Planning.
Androulakis I; Mestrom RMC; Christianen MEMC; Kolkman-Deurloo IK; van Rhoon GC
Sensors (Basel); 2022 Feb; 22(4):. PubMed ID: 35214230
[TBL] [Abstract][Full Text] [Related]
3. Optimisation-based thermal treatment planning for catheter-based ultrasound hyperthermia.
Chen X; Diederich CJ; Wootton JH; Pouliot J; Hsu IC
Int J Hyperthermia; 2010 Feb; 26(1):39-55. PubMed ID: 20100052
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
5. Design of the novel ThermoBrachy applicators enabling simultaneous interstitial hyperthermia and high dose rate brachytherapy.
Androulakis I; Mestrom RMC; Christianen MEMC; Kolkman-Deurloo IK; van Rhoon GC
Int J Hyperthermia; 2021; 38(1):1660-1671. PubMed ID: 34814784
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavities.
Stauffer PR; Rodrigues DB; Goldstein R; Nguyen T; Yu Y; Wan S; Woodward R; Gibbs M; Vasilchenko IL; Osintsev AM; Bar-Ad V; Leeper DB; Shi W; Judy KD; Hurwitz MD
Int J Hyperthermia; 2020; 37(1):1189-1201. PubMed ID: 33047639
[TBL] [Abstract][Full Text] [Related]
7. Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix.
Diederich CJ; Wootton J; Prakash P; Salgaonkar V; Juang T; Scott S; Chen X; Cunha A; Pouliot J; Hsu IC
Proc SPIE Int Soc Opt Eng; 2011 Feb; 7901():79010O. PubMed ID: 25076820
[TBL] [Abstract][Full Text] [Related]
8. Interstitial hyperthermia of the prostate in combination with brachytherapy : An evaluation of feasibility and early tolerance.
Kukiełka AM; Hetnał M; Brandys P; Walasek T; Dąbrowski T; Pluta E; Nahajowski D; Kudzia R
Strahlenther Onkol; 2013 Jun; 189(6):467-75. PubMed ID: 23604184
[TBL] [Abstract][Full Text] [Related]
9. Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure.
Kukiełka AM; Hetnał M; Dąbrowski T; Walasek T; Brandys P; Nahajowski D; Kudzia R; Dybek D; Reinfuss M
Strahlenther Onkol; 2014 Feb; 190(2):165-70. PubMed ID: 24317192
[TBL] [Abstract][Full Text] [Related]
10. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
12. High dose rate brachytherapy in the treatment of prostate cancer.
Vicini F; Vargas C; Gustafson G; Edmundson G; Martinez A
World J Urol; 2003 Sep; 21(4):220-8. PubMed ID: 12905008
[TBL] [Abstract][Full Text] [Related]
13. Use of novel thermobrachytherapy seeds for realistic prostate seed implant treatments.
Warrell G; Shvydka D; Parsai EI
Med Phys; 2016 Nov; 43(11):6033. PubMed ID: 27806619
[TBL] [Abstract][Full Text] [Related]
14. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
15. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer.
Wootton JH; Prakash P; Hsu IC; Diederich CJ
Phys Med Biol; 2011 Jul; 56(13):3967-84. PubMed ID: 21666290
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. A simple method of obtaining equivalent doses for use in HDR brachytherapy.
Nag S; Gupta N
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360
[TBL] [Abstract][Full Text] [Related]
18. Interstitial thermoradiotherapy: review on technical and clinical aspects.
Seegenschmiedt MH; Brady LW; Sauer R
Am J Clin Oncol; 1990 Aug; 13(4):352-63. PubMed ID: 2198798
[TBL] [Abstract][Full Text] [Related]
19. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
20. A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.
Pettersson N; Johansson KA; Alsadius D; Tucker SL; Steineck G; Olsson C
Acta Oncol; 2014 Jun; 53(6):815-21. PubMed ID: 24460070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
